Teva Pharma Files 8-K on Operations and Financials
Ticker: TEVJF · Form: 8-K · Filed: May 7, 2025 · CIK: 818686
| Field | Detail |
|---|---|
| Company | Teva Pharmaceutical Industries Ltd (TEVJF) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Teva dropped an 8-K on May 7th detailing financial results and operations.
AI Summary
Teva Pharmaceutical Industries Ltd. filed an 8-K on May 7, 2025, reporting on its Results of Operations and Financial Condition, and submitting Financial Statements and Exhibits. The filing details the company's operational and financial status as of the reporting date.
Why It Matters
This 8-K filing provides investors and stakeholders with crucial updates on Teva's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for reporting financial information and does not indicate any unusual risks.
Key Players & Entities
- TEVA PHARMACEUTICAL INDUSTRIES LTD (company) — Registrant
- May 7, 2025 (date) — Date of Report
- 001-16174 (company) — Commission File Number
- 124 Dvora Hanevi’a Street Tel Aviv 6944020 , Israel (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on Teva's Results of Operations and Financial Condition, and includes Financial Statements and Exhibits.
What is the exact date of this filing?
The exact date of this filing is May 7, 2025.
What is Teva Pharmaceutical Industries Ltd.'s Commission File Number?
Teva Pharmaceutical Industries Ltd.'s Commission File Number is 001-16174.
Where are Teva's Principal Executive Offices located?
Teva's Principal Executive Offices are located at 124 Dvora Hanevi’a Street, Tel Aviv 6944020, Israel.
What is the SIC code for Teva Pharmaceutical Industries Ltd.?
The Standard Industrial Classification (SIC) code for Teva Pharmaceutical Industries Ltd. is 2834 (Pharmaceutical Preparations).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF).